Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Wrap Technologies Inc (WRAP)
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-04
$1.16-0.85%
Close 2026-11-04 · 1-day change
NASDAQInformation TechnologyHardware, Equipment & PartsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for WRAP yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve cash flow from operations from negative $1.25M in Q1 2026 | Cash flow improved from negative $2.62M to negative $1.25M in Q1 2026. | Broken | Cash flow loss worsens beyond -$1.25M | Cash from operations: $-2.433M FY2026-Q2; GAAP. Published target: Cash flow loss narrows vs Q1 2026. Annual target cannot be compared with a quarterly or TTM observation. Aug 11, 2026-2,433,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, speculative growth business, not a proven durable compounder. The long-term thesis is in a watch state: revenue grew between the first two quarters of 2026, but operating losses continued and recent momentum and quality measures weakened.
WRAP trades at a substantial premium to peers, while the evidence says that premium is not justified and model confidence is low. The expectations gap is elevated, but the evidence does not specify which growth or profitability assumptions investors expect.
Near term, the next results carry risk: WRAP missed its most recent quarter, and the evidence flags a meaningful chance of another miss. Revenue rose from the first to the second quarter of 2026, but operating income remained negative; the supplied figures do not establish full-year growth delivery or commercial revenue from WrapShield, drone, counter-UAS, or international activity.
The multi-year thesis hinges on whether management can turn stated priorities, including roughly 100% revenue growth in 2026, into measurable commercial results while addressing ongoing losses. A guidance cut would be a negative signal; Fed rate cuts or steadier results and guidance from major technology companies could support the sector backdrop, but neither would establish WRAP’s execution.
Over the next 1 to 3 years, WRAP remains a high-risk growth story with early revenue progress but weak financial performance and limited evidence of delivery against its commercial priorities. The central question is whether growth becomes sustained, verifiable execution rather than continued expectations. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Operating losses are large but management focuses on improvement. |
| Intact |
| Operating loss worsens beyond -$4.77M |
Operating income: $-2.251M FY2026-Q2; GAAP. Published target: Operating loss narrows vs Q1 2026. Annual target cannot be compared with a quarterly or TTM observation. Aug 11, 2026-2,251,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve near 27% revenue growth in 2026 | A primary condition in Wrap Technologies Inc's published investment case. The stated target is >=27% YoY growth in 2026. | Intact | YoY revenue growth falls below ~27% in 2026 | Revenue growth: 102.77% FY2026-Q2; GAAP. Published target: >=27% YoY growth in 2026. Annual target cannot be compared with a quarterly or TTM observation. Aug 11, 2026102.766798 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “Wrap continues to target 100% revenue growth for 2026, with management’s confidence in that outlook supported by trends observed throughout Q1.” “First Quarter 2026 Financial Highlights (vs. Q1 2025): ● Revenue increased 45% to $1.1 million, compared to $0.8 million in the prior-year period ● Bookings totaled $3.2 million in Q1 2026, including approximately $1.1 million from domestic sales and $2.1 million from international sales, reflecting continued global demand for Wrap’s Non-Lethal Response solutions.” Revenue was $1.111 million in 2026-Q1. Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.27 → $-0.27 · observed estimates
$0.00B → $0.00B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.27 | $864,950 | 1 / 1 |
| 2026-07-25 | $-0.27 | $864,950 | 1 / 1 |
| 2026-07-26 | $-0.27 | $864,950 | 1 / 1 |
| 2026-07-27 | $-0.27 | $864,950 | 1 / 1 |
| 2026-07-28 | $-0.27 | $864,950 | 1 / 1 |
| 2026-07-29 | $-0.27 | $864,950 | 1 / 1 |
| 2026-07-30 | $-0.27 | $864,950 | 1 / 1 |
| 2026-07-31 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-01 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-02 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-03 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-04 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-05 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-06 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-08 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-09 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-10 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-12 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-13 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-14 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-15 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-16 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-17 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-18 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-19 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-20 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-21 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-22 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-23 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-24 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-25 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-26 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-27 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-28 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-29 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-30 | $-0.27 | $864,950 | 1 / 1 |
| 2026-08-31 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-01 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-02 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-03 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-04 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-05 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-06 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-07 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-08 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-09 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-10 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-11 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-12 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-13 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-14 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-15 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-16 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-17 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-18 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-19 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-20 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-21 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-22 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-23 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-24 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-25 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-26 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-27 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-28 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-29 | $-0.27 | $864,950 | 1 / 1 |
| 2026-09-30 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-01 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-02 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-03 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-04 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-05 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-06 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-07 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-08 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-09 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-10 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-11 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-12 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-13 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-14 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-15 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-16 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-17 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-18 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-19 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-20 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-21 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-22 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-23 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-24 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-25 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-26 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-27 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-28 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-29 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-30 | $-0.27 | $864,950 | 1 / 1 |
| 2026-10-31 | $-0.27 | $864,950 | 1 / 1 |
| 2026-11-01 | $-0.27 | $864,950 | 1 / 1 |
| 2026-11-02 | $-0.27 | $864,950 | 1 / 1 |
| 2026-11-03 | $-0.27 | $864,950 | 1 / 1 |
| 2026-11-04 | $-0.27 | $864,950 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Monthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.